| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Nicergoline | Nicergoline EP Impurity A | VL1610001 | View CAS 38536-28-6 |
| Nicergoline | Nicergoline EP Impurity B | VL1610006 | View CAS 35264-46-1 |
| Nicergoline | Nicergoline EP Impurity C | VL1610002 | View CAS 35155-28-3 |
| Nicergoline | Nicergoline EP Impurity D | VL1610005 | View CAS 20826-04-4 |
| Nicergoline | Nicergoline EP Impurity E | VL1610007 | View |
| Nicergoline | Nicergoline EP Impurity F | VL1610004 | View |
| Nicergoline | Nicergoline EP Impurity G | VL1610003 | View |
| Catalogue No. | VL1610005 |
| CAS No. | 20826-04-4 |
| Molecular Formula | C₆H₄BrNO₂ |
| Molecular Weight | 202.01 |
| Parent drug | Nicergoline |
| IUPAC Name | 5-Bromopyridine-3-carboxylic Acid |
| Synonyms | 5-Bromonicotinic Acid |
| References | SHINTOMI, KEIICHI, et al. “Pharmacological Effects of Nicergoline and Its Metabolites, Decomposition Products and Impurities in Animals.” Journal of Pharmacobio-Dynamics, vol. 10, no. 1, 1987, pp. 35–48, https://doi.org/10.1248/bpb1978.10.35. |
| Status | In-stock |
| ListName | Nicergoline EP Impurity D |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
